methyllycaconitine has been researched along with Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Jiang, Y; Li, R; Sun, Q; Ye, J; Zhang, W | 1 |
| Eisenach, JC; Gurun, MS; Parker, R; Vincler, M | 1 |
2 other study(ies) available for methyllycaconitine and Edema
| Article | Year |
|---|---|
Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Inflammation Mediators; Interleukin-6; Janus Kinase 2; Male; Muscarinic Antagonists; Nicotinic Antagonists; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M4; Signal Transduction; Spiro Compounds; STAT3 Transcription Factor; Tropicamide; Tumor Necrosis Factor-alpha | 2013 |
The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation; Injections; Male; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tumor Necrosis Factor-alpha | 2009 |